Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study11See Appendix Afor the list of participants in the MIRACL study. That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial Infarction

Publication | Closed Access

DOI

Citations

References

1998

Year

Gregory G. Schwartz, Michael F. Oliver, Michael Ezekowitz, Peter Ganz, David D. Waters, John P. Kane, Michele Texter, Milton L. Pressler, Donald M. Black, Bernard Chaitman,

The American Journal of Cardiology

Myocardial Ischemia ReductionCardiovascular EpidemiologyCardiovascular DiseasePharmacologyCardiovascular PharmacologyPreventive CardiologyAcute Myocardial InfarctionMiracl StudyAggressive Cholesterol LoweringPublic HealthMedicineCardiologyCoronary Artery DiseaseCoronary Heart DiseaseMyocardial Infarction